LISATA THERAP.INC.DL-001 (8NE) — Financial Flexibility Index
LISATA THERAP.INC.DL-001 (8NE) has a Financial Flexibility Index of -1.03x as of December 2025. Free cash flow of €-3.25 Million (operating CF €-3.25 Million minus capex €0.00) represents -1% of total liabilities (€3.14 Million). Also explore LISATA THERAP.INC.DL-001 net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
LISATA THERAP.INC.DL-001 Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for LISATA THERAP.INC.DL-001 across 5 annual periods. Check LISATA THERAP.INC.DL-001 (8NE) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for LISATA THERAP.INC.DL-001 (2021–2025)
Year-by-year free cash flow to debt coverage for LISATA THERAP.INC.DL-001. For the full company profile including market capitalisation, see 8NE market cap overview.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -5.07x | €-15.92 Million | €-15.95 Million | €3.14 Million | ▼ -48.8% |
| 2024 | -3.40x | €-19.36 Million | €-19.36 Million | €5.68 Million | ▼ -15.6% |
| 2023 | -2.95x | €-20.03 Million | €-20.03 Million | €6.80 Million | ▲ +5.4% |
| 2022 | -3.11x | €-20.89 Million | €-21.17 Million | €6.71 Million | ▲ +29.7% |
| 2021 | -4.43x | €-22.18 Million | €-22.25 Million | €5.01 Million | — |